[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Solid Tumor Drugs Sales Market Report 2017

October 2017 | 119 pages | ID: G1B2594E8A4EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Solid Tumor Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Solid Tumor Drugs for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Solid Tumor Drugs market competition by top manufacturers/players, with Solid Tumor Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AstraZeneca
  • Abbott Laboratories
  • Amgen Limited & Amgen Ireland Limited
  • Biogen
  • Baxter
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche
  • Eli Lilly and Company
  • Johnson & Johnson
  • GlaxoSmithKline
  • Celgene Corporation
  • Pfizer
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Small Molecules
  • Enzymes
  • Blood and Blood Components
  • Gene Therapy
  • Recombinant Proteins
  • Somatic Cells
  • Tissues
  • Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Solid Tumor Drugs for each application, including
  • Oncology
  • Radiology
  • Neurology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Solid Tumor Drugs Sales Market Report 2017

1 SOLID TUMOR DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Solid Tumor Drugs
1.2 Classification of Solid Tumor Drugs by Product Category
  1.2.1 Global Solid Tumor Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Solid Tumor Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Small Molecules
  1.2.4 Enzymes
  1.2.5 Blood and Blood Components
  1.2.6 Gene Therapy
  1.2.7 Recombinant Proteins
  1.2.8 Somatic Cells
  1.2.9 Tissues
  1.2.10 Vaccines
1.3 Global Solid Tumor Drugs Market by Application/End Users
  1.3.1 Global Solid Tumor Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Radiology
  1.3.4 Neurology
  1.3.5 Others
1.4 Global Solid Tumor Drugs Market by Region
  1.4.1 Global Solid Tumor Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Solid Tumor Drugs Status and Prospect (2012-2022)
  1.4.3 China Solid Tumor Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Solid Tumor Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Solid Tumor Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Solid Tumor Drugs Status and Prospect (2012-2022)
  1.4.7 India Solid Tumor Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Solid Tumor Drugs (2012-2022)
  1.5.1 Global Solid Tumor Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Solid Tumor Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL SOLID TUMOR DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Solid Tumor Drugs Market Competition by Players/Suppliers
  2.1.1 Global Solid Tumor Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Solid Tumor Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Solid Tumor Drugs (Volume and Value) by Type
  2.2.1 Global Solid Tumor Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Solid Tumor Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Solid Tumor Drugs (Volume and Value) by Region
  2.3.1 Global Solid Tumor Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Solid Tumor Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Solid Tumor Drugs (Volume) by Application

3 UNITED STATES SOLID TUMOR DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Solid Tumor Drugs Sales and Value (2012-2017)
  3.1.1 United States Solid Tumor Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Solid Tumor Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Solid Tumor Drugs Sales Price Trend (2012-2017)
3.2 United States Solid Tumor Drugs Sales Volume and Market Share by Players
3.3 United States Solid Tumor Drugs Sales Volume and Market Share by Type
3.4 United States Solid Tumor Drugs Sales Volume and Market Share by Application

4 CHINA SOLID TUMOR DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Solid Tumor Drugs Sales and Value (2012-2017)
  4.1.1 China Solid Tumor Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Solid Tumor Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Solid Tumor Drugs Sales Price Trend (2012-2017)
4.2 China Solid Tumor Drugs Sales Volume and Market Share by Players
4.3 China Solid Tumor Drugs Sales Volume and Market Share by Type
4.4 China Solid Tumor Drugs Sales Volume and Market Share by Application

5 EUROPE SOLID TUMOR DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Solid Tumor Drugs Sales and Value (2012-2017)
  5.1.1 Europe Solid Tumor Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Solid Tumor Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Solid Tumor Drugs Sales Price Trend (2012-2017)
5.2 Europe Solid Tumor Drugs Sales Volume and Market Share by Players
5.3 Europe Solid Tumor Drugs Sales Volume and Market Share by Type
5.4 Europe Solid Tumor Drugs Sales Volume and Market Share by Application

6 JAPAN SOLID TUMOR DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Solid Tumor Drugs Sales and Value (2012-2017)
  6.1.1 Japan Solid Tumor Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Solid Tumor Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Solid Tumor Drugs Sales Price Trend (2012-2017)
6.2 Japan Solid Tumor Drugs Sales Volume and Market Share by Players
6.3 Japan Solid Tumor Drugs Sales Volume and Market Share by Type
6.4 Japan Solid Tumor Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA SOLID TUMOR DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Solid Tumor Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Solid Tumor Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Solid Tumor Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Solid Tumor Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Solid Tumor Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Solid Tumor Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Solid Tumor Drugs Sales Volume and Market Share by Application

8 INDIA SOLID TUMOR DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Solid Tumor Drugs Sales and Value (2012-2017)
  8.1.1 India Solid Tumor Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Solid Tumor Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Solid Tumor Drugs Sales Price Trend (2012-2017)
8.2 India Solid Tumor Drugs Sales Volume and Market Share by Players
8.3 India Solid Tumor Drugs Sales Volume and Market Share by Type
8.4 India Solid Tumor Drugs Sales Volume and Market Share by Application

9 GLOBAL SOLID TUMOR DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 AstraZeneca
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Solid Tumor Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 AstraZeneca Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Solid Tumor Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Abbott Laboratories Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Amgen Limited & Amgen Ireland Limited
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Solid Tumor Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Biogen
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Solid Tumor Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Biogen Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Baxter
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Solid Tumor Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Baxter Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Bristol-Myers Squibb Company
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Solid Tumor Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Bristol-Myers Squibb Company Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 F. Hoffmann-La Roche
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Solid Tumor Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 F. Hoffmann-La Roche Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Eli Lilly and Company
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Solid Tumor Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Eli Lilly and Company Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Johnson & Johnson
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Solid Tumor Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Johnson & Johnson Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 GlaxoSmithKline
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Solid Tumor Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 GlaxoSmithKline Solid Tumor Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Celgene Corporation
9.12 Pfizer

10 SOLID TUMOR DRUGS MAUFACTURING COST ANALYSIS

10.1 Solid Tumor Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Solid Tumor Drugs
10.3 Manufacturing Process Analysis of Solid Tumor Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Solid Tumor Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Solid Tumor Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL SOLID TUMOR DRUGS MARKET FORECAST (2017-2022)

14.1 Global Solid Tumor Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Solid Tumor Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Solid Tumor Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Solid Tumor Drugs Price and Trend Forecast (2017-2022)
14.2 Global Solid Tumor Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Solid Tumor Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Solid Tumor Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Solid Tumor Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Solid Tumor Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Solid Tumor Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Solid Tumor Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Solid Tumor Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Solid Tumor Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Solid Tumor Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Solid Tumor Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Solid Tumor Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Solid Tumor Drugs Price Forecast by Type (2017-2022)
14.4 Global Solid Tumor Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Solid Tumor Drugs
Figure Global Solid Tumor Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Solid Tumor Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Small Molecules Product Picture
Figure Enzymes Product Picture
Figure Blood and Blood Components Product Picture
Figure Gene Therapy Product Picture
Figure Recombinant Proteins Product Picture
Figure Somatic Cells Product Picture
Figure Tissues Product Picture
Figure Vaccines Product Picture
Figure Global Solid Tumor Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Solid Tumor Drugs by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Solid Tumor Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Solid Tumor Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Solid Tumor Drugs Sales Volume (K Units) (2012-2017)
Table Global Solid Tumor Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Solid Tumor Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Solid Tumor Drugs Sales Share by Players/Suppliers
Figure 2017 Solid Tumor Drugs Sales Share by Players/Suppliers
Figure Global Solid Tumor Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Solid Tumor Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Solid Tumor Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Solid Tumor Drugs Revenue Share by Players
Table 2017 Global Solid Tumor Drugs Revenue Share by Players
Table Global Solid Tumor Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Solid Tumor Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Solid Tumor Drugs by Type (2012-2017)
Figure Global Solid Tumor Drugs Sales Growth Rate by Type (2012-2017)
Table Global Solid Tumor Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Solid Tumor Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Solid Tumor Drugs by Type (2012-2017)
Figure Global Solid Tumor Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Solid Tumor Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Solid Tumor Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Solid Tumor Drugs by Region (2012-2017)
Figure Global Solid Tumor Drugs Sales Growth Rate by Region in 2016
Table Global Solid Tumor Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Solid Tumor Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Solid Tumor Drugs by Region (2012-2017)
Figure Global Solid Tumor Drugs Revenue Growth Rate by Region in 2016
Table Global Solid Tumor Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Solid Tumor Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Solid Tumor Drugs by Region (2012-2017)
Figure Global Solid Tumor Drugs Revenue Market Share by Region in 2016
Table Global Solid Tumor Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Solid Tumor Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Solid Tumor Drugs by Application (2012-2017)
Figure Global Solid Tumor Drugs Sales Market Share by Application (2012-2017)
Figure United States Solid Tumor Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Solid Tumor Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Solid Tumor Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Solid Tumor Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Solid Tumor Drugs Sales Volume Market Share by Players in 2016
Table United States Solid Tumor Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Solid Tumor Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Solid Tumor Drugs Sales Volume Market Share by Type in 2016
Table United States Solid Tumor Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Solid Tumor Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Solid Tumor Drugs Sales Volume Market Share by Application in 2016
Figure China Solid Tumor Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Solid Tumor Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Solid Tumor Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Solid Tumor Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Solid Tumor Drugs Sales Volume Market Share by Players in 2016
Table China Solid Tumor Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Solid Tumor Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Solid Tumor Drugs Sales Volume Market Share by Type in 2016
Table China Solid Tumor Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Solid Tumor Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Solid Tumor Drugs Sales Volume Market Share by Application in 2016
Figure Europe Solid Tumor Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Solid Tumor Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Solid Tumor Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Solid Tumor Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Solid Tumor Drugs Sales Volume Market Share by Players in 2016
Table Europe Solid Tumor Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Solid Tumor Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Solid Tumor Drugs Sales Volume Market Share by Type in 2016
Table Europe Solid Tumor Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Solid Tumor Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Solid Tumor Drugs Sales Volume Market Share by Application in 2016
Figure Japan Solid Tumor Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Solid Tumor Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Solid Tumor Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Solid Tumor Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Solid Tumor Drugs Sales Volume Market Share by Players in 2016
Table Japan Solid Tumor Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Solid Tumor Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Solid Tumor Drugs Sales Volume Market Share by Type in 2016
Table Japan Solid Tumor Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Solid Tumor Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Solid Tumor Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Solid Tumor Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Solid Tumor Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Solid Tumor Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Solid Tumor Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Solid Tumor Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Solid Tumor Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Solid Tumor Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Solid Tumor Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Solid Tumor Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Solid Tumor Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Solid Tumor Drugs Sales Volume Market Share by Application in 2016
Figure India Solid Tumor Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Solid Tumor Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Solid Tumor Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Solid Tumor Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Solid Tumor Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Solid Tumor Drugs Sales Volume Market Share by Players in 2016
Table India Solid Tumor Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Solid Tumor Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Solid Tumor Drugs Sales Volume Market Share by Type in 2016
Table India Solid Tumor Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Solid Tumor Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Solid Tumor Drugs Sales Volume Market Share by Application in 2016
Table AstraZeneca Basic Information List
Table AstraZeneca Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure AstraZeneca Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure Abbott Laboratories Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Basic Information List
Table Amgen Limited & Amgen Ireland Limited Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Biogen Basic Information List
Table Biogen Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure Biogen Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure Biogen Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Baxter Basic Information List
Table Baxter Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure Baxter Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure Baxter Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Company Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure Eli Lilly and Company Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure Johnson & Johnson Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Solid Tumor Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Solid Tumor Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Solid Tumor Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Solid Tumor Drugs Revenue Global Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Pfizer Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumor Drugs
Figure Manufacturing Process Analysis of Solid Tumor Drugs
Figure Solid Tumor Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumor Drugs Major Players in 2016
Table Major Buyers of Solid Tumor Drugs
Table Distributors/Traders List
Figure Global Solid Tumor Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Solid Tumor Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Solid Tumor Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Solid Tumor Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Solid Tumor Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Solid Tumor Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Solid Tumor Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Solid Tumor Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Solid Tumor Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Solid Tumor Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Solid Tumor Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Solid Tumor Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Solid Tumor Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Solid Tumor Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Solid Tumor Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Solid Tumor Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Solid Tumor Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Solid Tumor Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Solid Tumor Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Solid Tumor Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Solid Tumor Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Solid Tumor Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Solid Tumor Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Solid Tumor Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Solid Tumor Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Solid Tumor Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Solid Tumor Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Solid Tumor Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories